Flotek Industries, Inc. (FTK) Earnings Call Transcript & Summary

August 10, 2021

New York Stock Exchange US Materials Chemicals earnings 58 min

Earnings Call Speaker Segments

Nick Bigney

executive
#1

Thanks, and welcome, everyone. On the line with me this morning are John Gibson, our Chairman, CEO and President; Michael Borton, our Chief Financial Officer; TengBeng Koid, who serves as President of Global Business; and Ryan Ezell, President of Chemistry Technologies. We'll begin today by offering some prepared comments about the business and how the quarter turned out. After that, we'll take whatever questions you might have. Our earnings announcement for the second quarter of 2021 went out yesterday, and you can find it on our website. A webcast of this call is happening now, and a replay will be posted on our site as well. Keep in mind that anything we say today about projections or what we expect in future periods counts as forward-looking statements. Such statements carry a range of risks and uncertainties, and many of those lie outside our control. Because of these risks and uncertainties, actual results could differ materially from what we currently expect, so we encourage listeners to look over our earnings release and the risk factors described in our SEC filings. We also ask that you consult the reconciliations included in our earnings press release, since non-GAAP metrics may come up during this call. With all of that said, I'll hand things over to John.

John Gibson

executive
#2

Okay, thanks, Nick, and good morning, everybody. To start, I want to talk about how we did in Q2, since Permian Basin market consolidation really left a mark on those results. During our Annual General Meeting in early June, we talked about how 2 of our biggest customers saw ownership changes during the quarter, and those deals closed faster than expected, which disrupted committed inventory as well as anticipated revenue. Over the course of my career, I've watched plenty of consolidation events like these, and it's quite typical that pauses in services or switches in vendors happen while companies work through integration. Talks are underway with both customers about becoming their green chemistry supplier; with one of them, we ought to be back to work before long. Within our Energy Chemistry business, Flotek has long carried a high level of customer concentration, and ever since I came to the company last year, broadening our customer mix has been a personal mission. Sadly, given the downturn, cutting our customer concentration has been difficult, yet we've kept making steady progress toward our diversification goals as the industry has started to recover. Since the industry is recovering, we've decided to speed up our sales strategy to broaden our customer base. We've diversified our revenue by growing the count of both E&P operators and oilfield services companies we sell to today compared with a year ago, and we expect revenue from our new customers to grow over the coming year. To lift revenue growth, we've also trimmed nonrevenue generating costs so we can add sales and marketing resources. Our expertise and passion have been aimed at delivering green chemistry and data solutions that lessen the environmental impact of energy production on air, water, land and people; we've catalyzed our shift to ESG, and we've engaged with the industry to show the strategic benefits of our sustainable chemistry and data solutions supporting our customers' ESGs and operational goals. Building on our decade-plus track record of supplying bio-based high-performance chemistries, we are today actively partnering with energy customers to maximize the convergence of asset performance, environmental protection, economic value and safety of the community. At bottom, we intend to help our customers in their efforts to sustain the social license to operate in every geography; the response we're receiving invigorates us as we raise awareness of the benefits of our green chemistry and real-time data solutions; in support of those efforts, we are actively engaging with one of the most influential accounting standards agencies to impact the industry's ESG chemistry reporting standards. The potential outcomes tied to this engagement excite me, because I firmly believe that what gets measured gets improved. Along those lines, as we have expanded our C-suite engagements, we are starting to see some competitive bids include ESG components when they evaluate chemistry partners. The emergence of ESG components and tenders works to our advantage. Last, we've partnered with an important customer to conduct an analysis of their chemistry usage to support their ESG reporting and performance. We see this scorecard as a model for how we'll engage with the industry going forward. And although these steps are quite positive, we still have work ahead on a broader scale — building awareness and prompting action so that toxic chemicals, including those made with xylene, get replaced by safer, renewable, sustainable options. Ryan will go deeper — offering detailed commentary on that point during his remarks. Removing obstacles to deploying essential ESG solutions requires tighter connectivity across our customers' organizations, so they can shift from ESG intent toward purchasing behavior at the well site. That shift is underway, but it must become a priority. We stand ready to help our customers through this change. Now let's turn to a few of the quarterly highlights. There's no denying that losing revenue tied to the ownership change of 2 customers just discussed hurt our Energy Chemistry business, yet it's worth noting that excluding those events, both our sales and adjusted EBITDA exceeded what we expected, which further confirms that our green chemistry focus is building momentum. During the quarter, we hit the 1-year mark since acquiring JP3, and I'm happy that our second quarter was JP3's strongest period since that acquisition; we keep advancing on entering international markets, and I'm delighted that our first international purchase order has come in, and you'll hear much more about that shortly from TengBeng Koid. We've taken several steps to shore up our balance sheet. First, we announced recently that a long-term lease agreement has been completed for our Waller, Texas facility with Resolute Oil, which will produce other income while offsetting our cost. Resolute leads globally in high-quality white mineral oil, and we're eager to look into ways to apply our respective green chemistries to adjacent markets we serve. We're also negotiating a lease for our Monahans facility, which will make it income-generating as well. In addition, during the quarter we obtained full forgiveness for the JP3 Paycheck Protection Program, or PPP loan, and we have filed for forgiveness of Flotek's PPP loan, with hopes of an update for you next quarter; and lastly, we're glad to have signed a term sheet for an asset-based line of credit, and we'll keep you posted as this agreement's details are finalized. On cost initiatives, as I mentioned earlier in my comments, we've realigned our structure to ensure we're built to capture the ESG opportunities ahead; recognizing clearly that now is the moment to grow our market share given our unique position and offerings. Consequently, we cut roles that weren't directly generating revenue and are reinvesting to grow our sales team. The net annualized cost savings comes to more than $1 million, including the reinvestment. Additionally, we are happy about being added to the Russell Microcap Index during June. That gives us a chance to become more visible among investors and to assist in broadening our shareholder base. Now, prior to handing this call to TengBeng and Ryan, I want to share a few remarks regarding some important new partners who have come aboard. To start, I want to officially welcome Lisa Mayr to our Board of Directors and Audit Committee. She truly — she brings strength to our governance. She possesses more than 25 years of experience in financial accounting and currently serves as CFO of Internap Holding, a provider of digital infrastructure. Lisa is a great addition, and I am confident she will make positive contributions right away to our Board and our company. I am also glad to welcome KPMG as our new audit partner. Our relationship only started in July, and the team and I are extremely impressed by their professionalism. I anticipate a cooperative partnership. And it astonishes me that KPMG and our team, within just 5 weeks, were able to get the Q out on schedule. So congratulations to both of you. We are delighted to have broadened our coverage to include NOBLE Capital Markets, and we welcome research analyst Michael Heim to our call, and we look forward to hearing his questions this morning, together with Daniel Burke, our highly regarded analyst for quite some time from Johnson Rice. Now I would like to turn the call over to TengBeng for more discussion on our Data Analytics segment. TengBeng?

Teng Beng Koid

executive
#3

Thanks, John, and good morning to all of you. Over in the Data Analytics segment, it's good to report that we keep seeing gains in the financials when it comes to revenue and gross margin. Revenue ticked up a bit during the quarter, which is a sequential improvement across the last 3 quarters and makes this our strongest quarter since we acquired JP3. The sales came from bringing on quite a few new customers, especially up in Canada, plus existing U.S. customers who keep coming back to buy more. These fresh orders along with repeat purchases from customers really demonstrate the strength of our transformative digital technology, which delivers real-time data and analytics to the people we serve. For Data Analytics, the second quarter brings 2 significant milestones. To start, we've finished the specifications and the manufacturing work on our Verax analyzer prototype built for international markets, and we're now in the last stage of going through extensive certifications, with hopes of securing the certificates needed for international deployment before long. Next, we've booked our very first international purchase order; this deal will serve a major international oil company, and it marks 2 thrilling firsts for JP3; the system is going to be installed on an offshore platform in Southeast Asia, which grows both our geographical footprint and the range of application use cases, that is, in an offshore environment. Even though we remain focused on onshore, upstream, midstream and downstream applications, securing a competitive bid that supports offshore operations confirms just how valuable our real-time data solutions are throughout the energy sector and opens up an exciting new frontier full of vast market opportunities. At JP3, our attention stays on carrying out our strategy, particularly around technology development, where our technology development road map is very robust and features plenty of new capabilities set to roll out in the near future; with that said, I'll hand the call over to Ryan Ezell so he can talk about our Chemistry Technologies segment. Ryan.

Ryan Ezell

executive
#4

Thanks, Koid. I'll start by covering how our Chemistry Technology segment performed, beginning with Energy Chemistry Technologies and then turning to professional chemistries. As John noted before, during the quarter, Energy Chemistry Technologies took a hit from the unplanned acceleration of M&A activity that touched 2 domestic customers. If you set aside that lost revenue, we would have beaten our quarterly growth projections and posted strong results. To give a little more detail on how that revenue loss tied to the market consolidation played out, had we counted the expected revenue recognition from those 2 customers, the business would have risen 22%. Even with these consolidation setbacks, we're confident that our strategy of being the collaborative partner of choice for sustainable chemistry is gaining traction, and we're sharply focused on growing our market share to include domestic and international E&P operators, plus service companies, which diversifies our revenue stack and reduces future risk from customer concentration. During the second quarter, we also took another look at our organizational structure to speed up these efforts. As a result, we implemented a number of structural changes and shifted resources to grow our sales and marketing efforts. Along those lines, we intend to double our sales force so it can drive broader adoption of our green chemistry solutions across the energy life cycle, while producing more than $1 million in annualized salary savings. That larger sales force will help us extend important fundamental progress from the second quarter, which includes, first, as we discussed last quarter, our green chemistries being used in an important field trial in the Permian Basin. Given the initial success, we're excited that the pilot has been expanded not only in scope to add new technology applications in the Permian, but also into new unconventional basins in North America. Second, we secured multiple new remediation treatment applications during the quarter that use our complex nano-Fluid technologies. This bio-based high-performance chemistry, built on nontoxic plant-based solvents, lets Flotek's customers cost effectively replace benzene, toluene, ethylbenzene and xylene, also known as BTEX, along with other harmful solvents, lowering the environmental risk of their remediation and production programs. In addition, we're pleased to announce a partnership with a very important customer to deliver an ESG scorecard assessment of their full well cycle chemistry utilization, so we can identify opportunities that support their ESG reporting goals and operational efficiencies. Beyond that, we've made notable progress rebuilding our indirect channels to market on the service company revenue side. Our indirect customer base rose by 58%, and domestic indirect channel revenue climbed 68% sequentially. We also grew our field safety performance, surpassing 2,000 days with no OSHA recordable or lost time incident. And last, we signed a multiyear deal with Resolute Oil, which is a top provider of premium white mineral oil serving consumer and industrial clients. Resolute Oil is going to use our chemical blending site in Waller, Texas, to produce USP and NF-grade white mineral oil for worldwide distribution. Plus, our plant is tailored for making green chemistries, and our customers are noticing how they can tap into our capabilities and facilities to fuel growth in nearby green markets. Now shifting to the professional chemistry business. In the second quarter, we experienced sequential volume gains overall, powered by strength in janitorial, disinfectants and cleaning products; and we're glad to see momentum building in these categories, which added to our better quarterly results, with revenue climbing over 30% from the prior quarter. During the quarter, we achieved positive strides in establishing key foundational relationships that will bolster our in-house sales team, headed by Jan-San veteran Matt Sullivan. These milestones consist of landing contracts with national and major large-scale distributors and redistributors. I'll now hand the call to Mike so he can go over our financial results.

Mike Borton

executive
#5

Thanks, Ryan. To pick up where those earlier remarks left off, I want to go deeper into how we performed financially during the quarter. Consolidated revenue for the quarter came in at $9.2 million, which represents growth of more than 3% compared with the $8.9 million recorded in the second quarter of 2020, though it fell short of the $11.8 million in revenue generated during the first quarter of 2021. Looking at it by segment, our Chemistry Technologies segment posted a 3% year-over-year revenue decrease in the second quarter, landing at $7.7 million, and a 25% sequential decrease relative to Q1 2021. The decline for Q1 '21 came mainly from losing the sales tied to the 2 domestic energy customers we discussed earlier on this call. Digging further into our Chemistry Technologies segment, Energy Chemistry experienced a sequential revenue decline as a result of losing those 2 clients. On a year-over-year basis, Energy Chemistry revenue — excluding raw terpene inventory — rose 87% in sales even with the lost sales from those clients we discussed previously. Professional chemistries improved on a sequential basis, helped by strength in degreasers and disinfectants, yet sales dropped significantly year-over-year, reflecting the peak COVID pricing and demand levels seen a year ago. Now turning to Data Analytics. Just to note, since JP3 came into the fold back in May 2020, we don't have a complete quarter-to-quarter comparison for that segment spanning a full year. On a sequential basis, revenue came in a bit stronger during the quarter. When we look at consolidated operating expenses, they hit $12.1 million during the second quarter of 2021 — that's a 12% drop from the prior quarter, but a 4% increase over the $11.6 million we recorded in last year's second quarter. The reason operating expenses rose year over year comes down to JP3: in Q2 2020 we only carried a half quarter's worth of its expenses, whereas Q2 2021 includes a full quarter of them. On the G&A side for the corporate segment, we saw a 34% decline compared with the first quarter of 2021. The main driver there was a $1.9 million employee retention credit that we received, which covers the credit for both Q1 and Q2. We also had lower contractor spend. Those benefits were partially offset by a severance accrual related to the personnel changes that John and Ryan mentioned earlier today. For the second quarter of 2021, our net loss came in at $6.5 million, which works out to a $0.09 loss per diluted share. That's a substantial improvement from the prior year, when we posted a net loss of $9.6 million, or a $0.14 loss per diluted share. For Q2, adjusted EBITDA came in at a loss of $6.7 million. That's a bit worse than the $6.5 million loss we posted a year ago, and it matches the $6.7 million loss from last year as well. Turning to the balance sheet now — keeping liquidity intact is still our main priority. We closed out the second quarter with $28 million in cash equivalents, which works out to roughly $0.40 per diluted share, compared with $33.9 million at the end of Q1. Several things weighed on our cash position: the operating losses and severance agreements from earlier periods. Those pressures were partly balanced out by employee retention credits and favorable shifts in working capital. During Q2, we were happy to announce that JP3 was granted complete forgiveness by the SBA on its Paycheck Protection Program, or PPP, loan amounting to $881,000, which showed up as other income for that period. In June, Flotek submitted a request to have a substantial share of the $4.8 million in PPP loans still sitting on the balance sheet forgiven as well. On top of that, we just put our signature on a term sheet for an asset baseline, which will serve as a tool for financing the working capital growth we expect as operations scale up. Finally, as both John and Ryan mentioned, we wrapped up a long-term lease deal covering our Waller facility, and talks are underway regarding operating our Monahan facility. At the close of Q2, our balance sheet continued to carry a $9.4 million accrued liability tied to the supply agreement the company previously had with ADM, which was booked during last year's fourth quarter. That $9.4 million figure reflects anticipated losses stemming from selling excess terpene past what we need for our clients' products. We'll keep reviewing this accrual on a quarterly basis. Also on the balance sheet is a $1.1 million receivable covering what remains of the employee retention credit cash benefit. Our tax net operating loss stands at $115 million, about $1 per diluted share, and it keeps increasing each quarter. At this point, I'll hand the call back over to John.

John Gibson

executive
#6

Okay, thanks, Mike. Appreciate it, Mike. Let me switch my microphone back on. Prior to opening things up for questions, I wanted to offer a handful of closing remarks. To start, I'm sure everyone is eager to know how Q3 is shaping up now that July has wrapped. We won't be giving guidance for the quarter, but I can tell you that our revenue figure for July exceeded every single month in Q2 2021; that's clearly an encouraging sign that we're moving along a strong trajectory; we achieved meaningful strides toward meeting the commitments we laid out, which shows we're steadily turning ambition into real action, since ultimately everything hinges on how well we carry out our strategy. Over the course of many months, we've been taking measures to strengthen our liquidity position further, and this quarter we came through on multiple fronts, with additional ones still ahead. I take great pride in the leasing arrangement we've put in place that transforms obligations into revenue. Ever since we brought JP3 on board, TengBeng and his team have been putting in dedicated effort to expand our Verax system internationally; during this quarter, we landed our initial purchase order and also finished our international prototype; we've continued making consistent headway in broadening who we serve within our Energy Chemistry business, and I feel very positive about what lies ahead with Ryan at the helm. Last of all, I'd suggest you check out the fresh investor presentation posted on our site; it captures what Flotek is right now and the distinctive value we bring in delivering ESG solutions to our clients. We'll be at the EnerCom Oil & Gas Conference happening next week, and I'm scheduled to speak on Tuesday afternoon, and we'd love for you to listen in on that too; so with that said, operator, let's go ahead and take questions from the floor.

Daniel Burke

analyst
#7

I'd like to kick things off with a question about JP3. Last year, COVID created a lot of disruption, so it's good to hear about the strides being made in certain international initiatives there. Could you take a step back and perhaps discuss the work being done to rebuild JP3's domestic business in the midstream and downstream areas, and also tell us where things stand with Phillips 66?

John Gibson

executive
#8

Glad to address that. I'll hand it over to TengBeng. But first, it's genuinely thrilling to have a sale in the Far East and one offshore; when you put those 2 together, that's our first offshore sale. And even that got affected by COVID, since the country found it — found it hard for us to actually get the equipment deployed because of COVID potentially being present on the platform offshore. So it remains an issue, and it's an issue that varies from country to country. With that, TengBeng.

Teng Beng Koid

executive
#9

Absolutely, John — regarding what you mentioned, COVID restrictions continue to have an impact on the international market. At first, we believed things were improving, but clearly the recent strain stopped us from deploying staff to set up a system in both the Middle East and the Far East. So we're trying to get those individuals over there; we had a handful of Saudis at our own sites. They're able to travel here, while it's hard for our team to go in the opposite direction. So we've now had them trained, and ideally we'll get things moving on the international side. Even with the COVID restrictions and every one of those challenges, we still succeeded in closing the international sale, and the pilot is advancing quite nicely too. There were several additional regions, additional nations where we'd hoped for some orders. And with the — for part of it, I believe some of that could bear fruit in maybe the coming 2 quarters. On the domestic side, Daniel, in response to what you asked, budgets at the midstream companies are beginning to loosen up. So we're making headway there. And particularly as we approach the end of the year, additional budgets will open and we'll see headway in that space; as for the Phillips 66 partnership, we keep moving forward. There are many customers — or rather, prospective customers — with whom we've been collaborating closely alongside Phillips 66. Actually, last week — last Friday — we held our joint collaboration partnership meeting with them once more, and we're making — I'd say we're making headway in spite of the COVID situation.

John Gibson

executive
#10

Yes, one more inquiry for you, Daniel.

Daniel Burke

analyst
#11

Absolutely, John. I value what you said regarding July, and it sounds positive. That said, I suppose, is there any possibility July might not accurately reflect how the entire quarter turns out? I simply want to avoid reading too much into it.

John Gibson

executive
#12

Right, reading too much into it isn't my goal either. Having to stand up at the AGM previously and announce a lost customer was not pleasant for me. So nothing like that is expected. What I mean is our position is considerably stronger now. Like Ryan mentioned, because of that we've already broadened our customer base quite a bit. That doesn't worry me. My top 2 worries would be COVID once more, plus the governmental response to it as #1, along with how customers respond. Then the other would be what we might term operational fatigue setting in during Q4. So at what point do they halt? Is Thanksgiving when they halt? Or is Christmas the point where they halt their spending for the year? So looking ahead to the back half, the bigger question is where the budget will be directed. And this COVID showing its face again. Apart from that, we're genuinely witnessing some strong improvements on the green chemistry front, which I might get a chance to touch on briefly. And it's — I feel optimistic, though I won't provide guidance.

Daniel Burke

analyst
#13

Maybe I'll close with just one more from my side. John, could you sum up your thoughts regarding green chemistry within the energy markets? You mentioned several conversations and what seem like promising early — honestly, I hesitate to even label them early — but initiatives you're observing out there in the field on the marketing front. Could you help us understand how wide-ranging those conversations actually are? Is that clear, as opposed to more isolated initiatives?

John Gibson

executive
#14

Sure, that works. I believe, if I may, I'll have Ryan weigh in on how remediation work is picking up and whatever else he's noticing when it comes to green adoption. Ryan.

Ryan Ezell

executive
#15

Absolutely, John. We're genuinely thrilled by what we're observing. Taking a broad, macro-level view of it, the discussions we used to have with C-suite leadership regarding green chemistry are now extending into numerous basin operations, as well as into some of the effects we're noticing on an international scale. When we examine the sort of business, the core, what sets Flotek apart is the more than 170 patents we hold covering green chemistry — the utilization of these natural bio-based solvents and similar things capable of substituting for BTEX. What we've truly accomplished is continued expansion in our simulation market; and with our customer base growing, we sell to the oilfield service companies and the direct NUCMP operator. We're noticing better uptake there. But what truly excites me is that we're now beginning to diversify into these various verticals somewhat further downstream on the remediation treatment. And we've witnessed considerable application improvement of the green-based chemistry on the remediation side, where historically xylene was used, or other BTEX related solvents, or other solvents of ours that are considerably nongross related; and we're going to watch that expand, and we're genuinely excited about the future regarding where that's heading on the vertical side; and we're also seeing that carry over into operations on the well construction side. And when I speak of well construction, I mean drilling fluids and cementing products, where we've seen considerable improvement with the oilfield service companies involved there, and that has resulted in some of the things we're examining around diversifying our customer base, since we're applying similar treatments for mud flushes and displacement treatments to achieve improved cement bond logs, et cetera; so plenty of applications on the green side that keep evolving; and the most notable thing, however, is that when you're out in the basins today, these discussions are finding their way into field operation conversations. And so that's a transitional trend we're observing that might not have been present previously — it was typically only C-suite sustainability messaging. So that's a genuinely positive step.

John Gibson

executive
#16

Still, Ryan, I'd say it's reasonable to note that during Q1-Q2, we completed 7 remediation jobs, getting rid of xylene, and we expect up to 40 in Q4...

Ryan Ezell

executive
#17

Yes, that's by the fourth quarter.

John Gibson

executive
#18

And so — and the upside in that area keeps expanding while we're talking about it. So, kind of moving from — and these aren't the same scale as stimulation jobs. So I don't want to exaggerate here, but I'd prefer opportunities with better margins and less revenue per well over ones with thinner margins and larger scope; so I believe there's a truly substantial chance for us in remediation.

Michael Heim

analyst
#19

I'd like a bit more detail about losing those 2 customers, and about your remark that one of them might bring some of the green business back. To be specific, what makes you think that will happen, and how soon? Are we talking about comparable figures, comparable sales to what you had before, perhaps even bigger? Also, where does the second customer stand?

John Gibson

executive
#20

That's a fair question. I won't get too deep into the specifics here. But those 2 customers — think of them as customer A and customer B when you look at our business. One of those losses, a really significant one for us, went to a customer that isn't using Flotek right now. They already have their own relationships and their own methodologies, and we are absolutely talking with them at the C-suite level, and throughout our organization we're engaged with them. Still, I'd say the odds of us coming back there are slimmer than with the second customer. Even so, we keep engaging with them constantly. And I truly look forward to doing business with them again down the road. As for the other customer, our expectation is that they return by Q4. We've engaged with the new owner, and it's a property we know well. In both cases, these properties performed better than offset operators. I'd say we contributed to that. Clearly, we aren't 100% of the reason. That's the case. But our chemistry genuinely contributed to their enhanced production and to the premiums these companies receive. So my hope is that we'll get out and tell that story and help other companies improve their production so that they receive premiums as well going forward. So one is gone. The other one comes back in Q4, and the one that's been gone a while, we are steadily working on.

Michael Heim

analyst
#21

Then I'd like to ask about the expense cuts you achieved this year; I realize you've mentioned the sales team, $1 million. Yet you did an excellent job bringing down costs elsewhere. I'm simply trying to understand, are those lasting savings or are they postponements and outlays that perhaps you made because revenue fell?

John Gibson

executive
#22

Ryan, how about you discuss the cuts you implemented so we could bring on additional salespeople.

Ryan Ezell

executive
#23

Absolutely. We examined a wide range of areas. What we've moved past includes realigning our cost of goods and our service delivery—specifically, where within the basin we procure chemicals, since that choice ripples into blending expenses, logistics outlays, and what operational support we require. On top of that, consistent with the value proposition and strategy we hold, we reviewed each and every position company-wide to determine whether value was being generated. That meant restructuring so we'd be fully, 100% oriented toward expanding revenue and plowing money back into growing the sales team, with emphasis on our green chemistry applications—and that's what we accomplished. Most of the operational and structural adjustments should stick even as we achieve substantial growth; and I'd say, possibly, any revenue-focused additions would represent potential upside in terms of how many more salespeople we bring on for coverage, since we're now considering representation tailored to specific basins and customers, and so forth, moving forward. So my expectation is that many of these structural changes will be retained. They weren't merely retention payments or anything like that.

Michael Heim

analyst
#24

Now, regarding the reorganization of the sales team, previously you mentioned it might be roughly a 3 to 6 month type of thing. Does that remain a reasonable figure to apply? And how far along would you say we currently are? Did my question get through?

Michael Heim

analyst
#25

Absolutely. Actually, that was my final question, so I somewhat apologize for prolonging the call, but I was simply inquiring about the sales force restructuring, which previously I've heard you describe as perhaps a 3 to 6 process to become operational, so I just wanted to get a feeling for where we stand in that process and when you expect matters will be finished?

John Gibson

executive
#26

That's an excellent question. I'm sorry for the silence there. I worked as a radio disc jockey in my youth, and I would have been terminated for such a lengthy pause. So I'm quite attuned to dead air. Regarding the sales force, we've adopted a somewhat different strategy. We're bringing on board primarily individuals we're familiar with who possess experience and grasp this industry and are acquainted with the customers, so we believe we'll reduce any lag between when they arrive here and when they can start producing revenue. Ryan, do you have anything to add?

Ryan Ezell

executive
#27

Absolutely, John. What I'd emphasize is that our focus is squarely on seasoned professionals — people at the mid-career stage and beyond — who bring the relationships and the fit with what we're offering and the opportunities we're chasing in the basin. So this has been quite a thorough effort on the hiring and interview side, and we've been pushing it hard right now. Several people have already come aboard, and we anticipate wrapping it up within the next few weeks so everyone is up and running. And that momentum is paying off nicely for us as things stand.

John Gibson

executive
#28

What also gets me fired up, the second item, is this: I'm drawn to folks with real drive, and Ryan has shifted the pay structure at this company so that less is guaranteed and a bigger portion rides on performance, and we're bringing in genuinely strong individuals who are convinced they can earn well here by capitalizing on that performance-based portion. So to me, that's an excellent step for this organization. It brings our expenses down and sharpens how aggressively our sales team operates.

Michael Heim

analyst
#29

I was on the verge of asking how you can expand the sales force while simultaneously bringing down costs, but I think your answer to that last question kind of covered it; so I'll wrap up — that's genuinely everything I wanted to ask.

Eric Swergold

analyst
#30

You already mentioned xylene and gave a few specifics about it. But what would need to happen for xylene to be banned by legislation in situations where contamination of groundwater could occur.

John Gibson

executive
#31

Ryan?

Ryan Ezell

executive
#32

Absolutely, and this is something we’ve spent a fair amount of time discussing. I’d frame it as a contrast between how aware companies are and how far legislation has actually moved; on the well construction side, it’s essentially been taken out completely. With drilling fluids, cementing, and the other uses where it has served as a mud breaker, for cleaning, and for dissolution, I’d say the challenge you often encounter when it’s first applied—whether in production or remediation—is that operators frequently don’t treat it as a closed system, so they aren’t seeing that annular disruption problem. In truth, we all understand that it does occur. So I’d say this remains front and center: even within a closed system, our focus is on making customers aware of the dangers of transporting it and using it where there’s human contact. Along with the broader possibility of releases into the environment, that’s helping build awareness about how xylene is applied, especially in places that are environmentally sensitive, such as the North Slope and certain higher basins in mountainous areas and similar locations we come across. As for how the legislative side shapes up, I believe that’s a much longer path, and there are conversations taking place about it. Still, I definitely believe the adoption by operators—and even among our service companies—will continue; service companies tend to know about this because of what happens in the well construction portion of the business.

John Gibson

executive
#33

That's going to take place. One segment of this industry has already done away with it. Consequently, going forward, my expectation is that you'll witness this starting with those states taking a tougher stance on rules for the environment. So expect Colorado, Alaska — those places will act before others on this, plus New England too. Yet without question it's coming; and what's taking place on our end is that customers are telling us, alright, now is when we need to act and make our green scorecard better, make our ESG score better.

Ryan Ezell

executive
#34

To build on that point, the single area where this has already occurred is internationally, with offshore uses. That application has been entirely prohibited, and customers are changing over — in places where they previously relied on xylene for various flushes and other such purposes, they have shifted to — wherever operations require zero discharge conditions, xylene is being eliminated. So the shift is happening and heading that way.

Eric Swergold

analyst
#35

My following inquiry concerns creating value rather than running the business day to day. You currently have a considerable amount of worth tied up in your NOLs, and I've noticed quite a few newly created ESG-focused equities that have not deployed any capital whatsoever. Suppose this company got a sizable influx of cash by way of a SPAC — what would your leading 3 priorities be when it comes to deploying those funds toward growing the operation?

John Gibson

executive
#36

That's yet another terrific question looking ahead. Eric, absolutely, without a doubt we would begin by growing the sales team. There's a great deal of opportunity in front of us, and I simply wish I had additional staff to pursue it. Extending internationally via that sales team would be an essential focus, since, as Ryan noted, we have never done business overseas during my time here; and my understanding is that a substantial offshore operation has never existed for them; yet when we examine overseas markets, the zero discharge mandates in place across Western Africa, the North Sea, and Asia truly present a tremendous chance for us to remove xylene. So the sales team plus reaching into those regions would matter a lot; through JP3 we have abundant chances to introduce sensors or add measurement functionality, allowing us to go past merely determining hydrocarbon composition and also identify and quantify amounts of greenhouse gases or other molecules we care about, water included. Consequently, I believe that's a space where we could right away put money to work and enlarge what JP3 makes possible for us. And last, regarding that third item, Ryan, please go ahead.

Ryan Ezell

executive
#37

Looking at it from that angle, I'd fully agree — 100% — about the position we're in regarding what our sales force costs relative to the opportunities. Beyond that, I believe potential exists now that we've gotten our operational structure component aligned. There are opportunities for us to put money into certain operational components, which would generate still better cost efficiency for us, in the areas where we've been — at a number of those entry points we've had across the basins for various lease programs. We're able to shift toward issuance of capital. Then the last piece, I'd say, is that we've been operating very lean as we've gotten our value proposition aligned within our green chemistry part. I think backing some of the extra marketing and sales communications for us would be the concluding element we examine when it comes to investment parts on the Chemistry Technologies proponent.

Eric Swergold

analyst
#38

For my third one, I'd ask something aimed at those just getting familiar with the story. You've taken a lot of steps to bring management's interests in line with shareholders'. Could you walk us through where the equity incentives currently stand, and what targets must be hit before you folks actually earn serious money for yourselves?

John Gibson

executive
#39

Eric, our alignment with the share price is quite strong. Essentially, a $3 trigger is needed before much of the vesting happens, especially in my case. Looking at this year — my wife urged me not to declare on a conference call that I wouldn't accept a bonus, since she knows I'll stick to my word. But absent a rising share price and better revenue results, I'd repeat what I did before this year. My view is that an award isn't deserved if we haven't reversed course; still, my confidence is growing that bonuses lie ahead for me; so I'm putting effort into that; and everybody at this company is tied to share price accretion as the route to receiving any of their awards. This year we shifted to a scorecard approach, working alongside our New Comp Chair, Harsha Agadi. Each item on those scorecards is tied — mainly tied — to the company's revenue growth too, and the scorecards make that plain. They also preserve the weight given to safety and the environment. As Ryan mentioned, we've gone 2,000 days — over 2,000 days — with no OSHA incident. That's an impressive figure, and strong management teams perform well on safety, which matters to us too. Even so, our alignment is complete. Should the share price fail to climb, not one of us will feel good about our own target earnings. So we stand with you.

John Bair

analyst
#40

There are a few things I'd like to ask about. I want to go back and revisit those 2 customers once more. Personally, I'm pleased you addressed that — the mergers, accelerate, and all of that. I just want to make it clear: are you essentially saying that customer #1 is no longer a possibility for the foreseeable future? Is that what I'm hearing?

John Gibson

executive
#41

That's about right. I don't want to sound too hopeful about it. Talks are ongoing with them. However, in certain situations, they're locked into agreements with other chemistry providers, and we must hold off until those run out. Then they'd fold the acquisition into their business and take advantage of the volume and discounts they may already have with a different chemistry supplier, meaning you have to wait for the next tender. It's common for them to have 2-year tenders; here, we're probably a year past when it happened before we can truly get that door open. Still, that doesn't rule out getting in and landing new work. We do have differentiated offerings that make that possible. So we've never eased up with these guys, saying we can help you, we can make you better. It's a solid company. The thing is, we had no relationship there before the acquisition, so we're having to build one after it. As for the other company, the relationship is strong on both sides. So I believe we're back in there; it's simply a question of when they begin actively working again.

John Bair

analyst
#42

Turning to that second customer, is it fair to assume you could land more work from the combined relationship, which might assist in counterbalancing what you might call that hold on the first customer?

John Gibson

executive
#43

What I'd say is our budget stands as our budget whether those customers are counted or not when it comes to our bonuses. So you can take it that when we rise each morning, we intend to fill those gaps. Additional business has to be won by us. For the management team to earn anything through bonuses, going out and substituting for them serves our own interest. It's simply unlucky that customer A and B are the two involved. Still, hopefully that stands as proof of the worth we generate alongside our customers, especially these private equity health customers or individual health customers.

John Bair

analyst
#44

What I’m really asking—setting bonuses to one side, all right—is that I’m simply attempting to get a sense that customer B together with what sounds like the company that ought to be acquired...

John Gibson

executive
#45

Ought to provide us with upside...

John Bair

analyst
#46

I was asking whether the business you bought had been your main client, meaning you could generate extra sales from the company doing the buying.

John Gibson

executive
#47

Correct. Certainly, with regard to that second client, there ought to be room to grow. Something else — a client that had been absent for 2 years has returned, and my hunch is they'll bring in more revenue than the client we parted ways with as we move ahead together; things are going really well with them; they make an excellent partner. They're bringing us into other basins, and they're broadening what we can offer. So we have plenty of grounds to feel sure that this was simply how acquisitions and integration work, which is why we came up short. And that is — it's a solid — excellent observation, John. Bad performance wasn't the reason we shed these contracts. Pricing wasn't the reason we shed these contracts. A rival wasn't the reason we shed these contracts. What took these contracts from us were acquisitions in which prior agreements already existed, and those buyers are respecting them, so we must go back in and sell once more. Therefore, there is essentially nothing wrong with Flotek and the fact that these clients departed. It's merely a transactional matter that happens during M&A.

John Bair

analyst
#48

Got it. I was only checking whether there might be additional upside. All right. Let's turn to something else. You said JP3, the Asia Pacific offshore business, was your first venture into an offshore setting. So what has been the holdup for you so far — or for JP3, I should say — in the Gulf of Mexico and the United States, apart from the fact that operations or activity in that region have been fairly subdued overall? But then, what does that opportunity look like for you too?

Teng Beng Koid

executive
#49

Absolutely, opportunities exist. When JP3 was launched, I believe the emphasis was genuinely onshore, which is the correct approach — onshore, covering both upstream, and particularly midstream, along with downstream. So at this point — and this timing is somewhat lucky, right when — it was a different party that they had been considering for that acquisition. Then they caught wind of us, and we walked them through what we can do; they were impressed enough that they chose to go with us rather than what they had typically been purchasing from. And at that point we came to see that this actually cracks open a market we had never even thought about before, since our attention has been overwhelmingly on onshore operations here in North America. So it creates an opening in the Gulf of Mexico, and also for offshore work in other parts of the world.

John Bair

analyst
#50

Brazil? Yeah. All right. That’s quite interesting. So are you putting direct attention right now into trying to build that up? I mean, are some members of your sales team now zeroing in specifically on the Gulf of Mexico, offshore Brazil, and Africa?

Teng Beng Koid

executive
#51

Well, so over here in North America, we actually brought on someone not long ago whose attention was truly on the upstream side. So yes, our attention will be directed at the Gulf of Mexico.

John Gibson

executive
#52

That's a solid question. Let me put it in somewhat different terms. The thing they're truly after when operating offshore—especially around the Gulf of Mexico, which is starting to rebound after an extremely weak stretch for that market—is being able, once activity picks back up, to fingerprint the crude they produce so they can command a premium tied to the reduced CO2 emissions linked to that oil. Picture it this way: through our partnership with JP3, we're able to identify which crude carries what level of CO2, and they are figuring out how to capture premiums built on the lower CO2 emissions connected to particular production. So we're working through the question of how to back that objective—fingerprinting hydrocarbons to unlock premiums.

John Bair

analyst
#53

Regarding how cost-competitive green chemistry assets were previously compared with conventional hydrocarbon-based fluids and similar products — with raw material prices having gone up and all — have you noticed that gap getting any smaller? Where does that stand now? I realize you've had no problems on the production side with the supply chains for making your green chemicals.

Ryan Ezell

executive
#54

From our standpoint, what we've observed is this — given where we sit with our renewable and plant-derived natural solvents — the differentiation in our pricing has pretty much become almost entirely closed when it comes to the advanced formulations we offer and their applications; and really, we've witnessed an effect on more of what I'd call the conventional chemistries, whether that's monobutyl ether, the glycols, or other products used in less environmentally friendly solvents — those have actually risen. That leaves us in a quite workable and solid price band to pursue these opportunities. And historically, we've made considerable progress with the resources in our research and innovation team to reformulate and deliver some highly cost-effective choices that can absolutely compete directly against the traditional BTEX solvents along with certain other mutual solvents. So that's been excellent for us; when it comes to supply, we're encountering comparable disruptions everywhere, yet none of it affects our green chemistry. The impact falls more on the other hydrocarbon-related solvents.

John Gibson

executive
#55

Alright, I want to thank each of you for joining us on this call today. I'm also grateful for the backing we get from our shareholders and for the honest exchanges we share. Everyone here is concentrated on generating profits for you; that's the reason we're doing this, and it's our purpose; we're thankful for the chance to serve you and we're eager to be with you on the upcoming call; and I can't wait until we're finally in a position to deliver some strong results at some point. So I believe everything we're carrying out gives us a chance to get better, and we simply have to remain disciplined and keep executing as we move ahead. The market is getting better, and we'll give it our all. We're grateful to you, and we'll speak again before long.

Operator

operator
#56

That brings us to the end of this call. We appreciate you joining us for today's presentation. You're welcome to disconnect at this time.

Read the full transcript via the API

You're viewing the first half of this call. Get the complete Flotek Industries, Inc. transcript — plus 132,000+ transcripts from 7,000+ companies, speaker segments, AI summaries and full-text search — through the EarningsCalls.dev API.

Get the API View API docs →

This call discussed

For developers and AI pipelines

Programmatic access to Flotek Industries, Inc. earnings transcripts and 132,000+ others is available through the EarningsCalls.dev REST API. Plans from $39.99/month — full transcripts, speaker segments, full-text search, and the recently-added /api/v1/transcripts/recent polling endpoint for ETL pipelines.

More tools for stock research

OptionsBell: an unusual options activity scanner that tracks options flow across all US stocks and emails you when large trades appear in Flotek Industries, Inc. or any ticker on your watchlist.

StockMarketScan: a stock screener with alerts: 24 pre-built screens refreshed every 5 minutes, watchlists and email notifications. Both offer API and MCP access and fair monthly pricing.